Raj K. Puri mainly focuses on Molecular biology, Receptor, Interleukin 13, Immunology and Interleukin 4. His Molecular biology research incorporates elements of Tyrosine kinase, Embryoid body and Stem cell, Cell biology. In his work, Differentially expressed genes is strongly intertwined with Gene expression profiling, which is a subfield of Stem cell.
Raj K. Puri has researched Receptor in several fields, including Cell culture, Pseudomonas exotoxin, Protein subunit and Fusion protein. His studies deal with areas such as Exotoxin, Cytotoxic T cell, Cancer cell and Glioma as well as Pseudomonas exotoxin. His work carried out in the field of Immunology brings together such families of science as Fibrosis, Pulmonary fibrosis and Lung.
Raj K. Puri mainly investigates Cancer research, Receptor, Molecular biology, Immunology and Pseudomonas exotoxin. In his study, which falls under the umbrella issue of Cancer research, Cancer and Toxicity is strongly linked to Pathology. His studies in Receptor integrate themes in fields like Cell culture and Interleukin 13, Interleukin 4.
His Molecular biology research includes themes of Endocrinology, DNA microarray, Gene expression, Transfection and Cell biology. The Immunology study combines topics in areas such as Pulmonary fibrosis and Combination therapy. His Pseudomonas exotoxin study combines topics in areas such as Exotoxin, Virology, Immunotoxin, Fusion protein and Cytotoxic T cell.
His scientific interests lie mostly in Cancer research, Cancer, Immunology, Internal medicine and Interleukin-13 receptor. His Cancer research research is multidisciplinary, incorporating elements of Cell culture, Head and neck squamous-cell carcinoma, Receptor, Immunotoxin and Pseudomonas exotoxin. His Pseudomonas exotoxin study incorporates themes from Cytotoxic T cell, Clonogenic assay, Glioma and Pathology.
His Immune system study combines topics from a wide range of disciplines, such as Cellular differentiation and Gene expression profiling. In his research, CD3 is intimately related to Molecular biology, which falls under the overarching field of Gene expression profiling. His Proinflammatory cytokine research incorporates themes from Fibrosis and Interleukin 13.
Raj K. Puri focuses on Cancer, Immunology, Clinical trial, Cell and Internal medicine. His Cancer study integrates concerns from other disciplines, such as Immunohistochemistry, Immunostaining and Intensive care medicine. The Immunology study combines topics in areas such as A549 cell and Silicosis.
His research in Cell intersects with topics in Mesenchymal stem cell, Stem cell and Cell biology. His work in CD24 tackles topics such as Cancer research which are related to areas like Common gamma chain. His study in Cancer stem cell is interdisciplinary in nature, drawing from both Receptor, Immune receptor, Janus kinase 1 and Signal transduction.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements
Leming Shi;Laura H. Reid;Wendell D. Jones;Richard Shippy.
Nature Biotechnology (2006)
IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis.
Stefan Fichtner-Feigl;Warren Strober;Koji Kawakami;Raj K Puri.
Nature Medicine (2006)
The Microarray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models
Leming Shi;Gregory Campbell;Wendell D. Jones;Fabien Campagne.
Nature Biotechnology (2010)
Gene expression in human embryonic stem cell lines: unique molecular signature
Bhaskar Bhattacharya;Takumi Miura;Ralph Brandenberger;Josef Mejido.
Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma.
Sandeep Kunwar;Susan Chang;Manfred Westphal;Michael Vogelbaum.
Receptor for Interleukin 13: INTERACTION WITH INTERLEUKIN 4 BY A MECHANISM THAT DOES NOT INVOLVE THE COMMON γ CHAIN SHARED BY RECEPTORS FOR INTERLEUKINS 2, 4, 7, 9, AND 15
Nicholas I. Obiri;Waldemar Debinski;Warren J. Leonard;Raj K. Puri.
Journal of Biological Chemistry (1995)
MSC-based product characterization for clinical trials: an FDA perspective
Michael Mendicino;Michael Mendicino;Alexander M. Bailey;Keith Wonnacott;Raj K. Puri.
Cell Stem Cell (2014)
The balance of reproducibility, sensitivity, and specificity of lists of differentially expressed genes in microarray studies
Leming Shi;Wendell D. Jones;Roderick V. Jensen;Stephen C. Harris.
BMC Bioinformatics (2008)
The External RNA Controls Consortium: a progress report.
Shawn C Baker;Steven R Bauer;Richard P Beyer;James D Brenton.
Nature Methods (2005)
A Novel Chimeric Protein Composed of Interleukin 13 and Pseudomonas Exotoxin Is Highly Cytotoxic to Human Carcinoma Cells Expressing Receptors for Interleukin 13 and Interleukin 4
Waldemar Debinski;Nicholas I. Obiri;Ira Pastan;Raj K. Puri.
Journal of Biological Chemistry (1995)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: